rrently serves as Senior Vice President and Chief Business Officer of The Medicines Company (NASDAQ: MDCO). Prior to that, he was Founder and CEO of the Brilleon Group a venture capital firm focusing on early and late-stage biotech opportunities in Europe and the US. Prior to that he was Co-Managing Director of AP